| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |